Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites.
Trypanosoma brucei cannot synthesize purines de novo and relies on purine salvage from its hosts to build nucleic acids. With adenosine being a preferred purine source of bloodstream-form trypanosomes, adenosine kinase (AK; EC 2.7.1.20) is likely to be a key player in purine salvage. Adenosine kinase is also of high pharmacological interest, since for many adenosine antimetabolites, phosphorylation is a prerequisite for activity. Here, we cloned and functionally characterized adenosine kinase from T. brucei (TbAK). TbAK is a tandem gene, expressed in both procyclic- and bloodstream-form trypanosomes, whose product localized to the cytosol of the parasites. The RNA interference-mediated silencing of TbAK suggested that the gene is nonessential under standard growth conditions. Inhibition or downregulation of TbAK rendered the trypanosomes resistant to cordycepin (3'-deoxyadenosine), demonstrating a role for TbAK in the activation of adenosine antimetabolites. The expression of TbAK in Saccharomyces cerevisiae complemented a null mutation in the adenosine kinase gene ado1. The concomitant expression of TbAK with the T. brucei adenosine transporter gene TbAT1 allowed S. cerevisiae ado1 ade2 double mutants to grow on adenosine as the sole purine source and, at the same time, sensitized them to adenosine antimetabolites. The coexpression of TbAK and TbAT1 in S. cerevisiae ado1 ade2 double mutants proved to be a convenient tool for testing nucleoside analogues for uptake and activation by T. brucei adenosine salvage enzymes.
Lüscher
Alexandra
A
Institute of Cell Biology, University of Bern, Baltzerstrasse 4, CH-3012 Bern, Switzerland.
Onal
Pinar
P
Schweingruber
Anne-Marie
AM
Mäser
Pascal
P
D000241:Adenosine / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology; D000248:Adenosine Kinase / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D015152:Blotting, Northern; D015139:Blotting, Southern; D015153:Blotting, Western; D003839:Deoxyadenosines / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D020868:Gene Silencing; D005816:Genetic Complementation Test; D009154:Mutation; D010802:Phylogeny; D015800:Protozoan Proteins / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D034622:RNA Interference; D012441:Saccharomyces cerevisiae / Q000201:enzymology / Q000235:genetics; D014344:Trypanocidal Agents / Q000737:chemistry / Q000494:pharmacology*; D014346:Trypanosoma brucei brucei / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism
D003839:Deoxyadenosines; D015800:Protozoan Proteins; D014344:Trypanocidal Agents; D000248:Adenosine Kinase; C058120:cordycepin; D000241:Adenosine
Mol Pharmacol. 1999 Dec;56(6):1162-70
10570043
J Biol Chem. 1987 Apr 25;262(12):5515-21
3032935
J Mol Biol. 2000 May 19;298(5):875-93
10801355
J Pharmacol Exp Ther. 2000 Dec;295(3):1156-64
11082453
Mol Biochem Parasitol. 2000 Nov;111(1):87-94
11087919
Yeast. 2001 Mar 15;18(4):335-42
11223943
J Mol Med (Berl). 2001 Apr;79(2-3):121-7
11357935
Mol Biochem Parasitol. 2001 Jun;115(1):19-28
11377736
J Biol Chem. 2002 Jun 14;277(24):21499-504
11937511
Curr Genet. 2003 Sep;43(6):400-6
12827445
Mol Biochem Parasitol. 2006 Jan;145(1):117-20
16269191
Biochem J. 2006 Feb 15;394(Pt 1):35-42
16271040
Proteomics. 2006 Jun;6(11):3275-93
16622829
Mol Biochem Parasitol. 2006 Oct;149(2):223-30
16879885
Biochem Pharmacol. 2007 May 15;73(10):1558-72
17306769
Eukaryot Cell. 2003 Oct;2(5):1003-8
14555482
J Med Chem. 2004 Apr 8;47(8):1987-96
15055998
Eukaryot Cell. 2004 Apr;3(2):245-54
15075255
Acta Trop. 2004 Jul;91(2):131-43
15234662
Trans R Soc Trop Med Hyg. 1972;66(2):354-5
4558831
J Bacteriol. 1976 Nov;128(2):689-91
789363
FEBS Lett. 1977 Aug 15;80(2):360-4
142663
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
271968
Acta Trop. 1979 Sep;36(3):289-92
43092
Parasitology. 1980 Oct;81(2):383-93
7443300
Biochem Biophys Res Commun. 1982 Jul 16;107(1):381-8
6289826
Mol Biochem Parasitol. 1982 Oct;6(4):209-23
6292713
Acta Trop. 1982 Sep;39(3):219-24
6128890
Biochim Biophys Acta. 1982 Nov 24;719(2):223-31
6817814
Proc Natl Acad Sci U S A. 1983 Nov;80(21):6667-70
6579551
Mol Biochem Parasitol. 1983 Sep;9(1):15-28
6199667
Mol Biochem Parasitol. 1984 Jun;12(2):139-51
6090896
Ann Trop Med Parasitol. 1985 Feb;79(1):7-11
3920982
Tissue Cell. 1985;17(6):793-800
4089860
Proc Natl Acad Sci U S A. 1989 Apr;86(8):2607-11
2704738
Nature. 1993 Jan 14;361(6408):173-6
8421523
Biochem J. 1994 Mar 1;298 ( Pt 2):295-301
8135734
Annu Rev Microbiol. 1994;48:105-38
7826002
FEMS Microbiol Lett. 1995 Mar 15;127(1-2):23-8
7737480
Science. 1995 May 26;268(5214):1179-83
7761835
Biochem Pharmacol. 1995 May 17;49(10):1501-12
7763293
Proc Int Conf Intell Syst Mol Biol. 1995;3:114-20
7584426
J Biol Chem. 1995 Nov 24;270(47):28153-7
7499305
Toxicol Appl Pharmacol. 1997 Nov;147(1):39-45
9356305
Acta Trop. 1997 Nov;68(2):139-47
9386789
Mol Biochem Parasitol. 1999 Mar 15;99(1):89-101
10215027
Science. 1999 Jul 9;285(5425):242-4
10398598
Antimicrob Agents Chemother. 1999 Oct;43(10):2437-43
10508021
Mol Biochem Parasitol. 1999 Sep 20;103(1):1-14
10514076
Mol Biochem Parasitol. 1999 Sep 20;103(1):15-23
10514077
Eur J Biochem. 1999 Nov;265(3):1015-21
10518797
Biochem J. 2005 May 1;387(Pt 3):591-600
15606359
Science. 2005 Jul 15;309(5733):416-22
16020726
Mol Pharmacol. 2005 Sep;68(3):589-95
15933219
J Infect Dis. 2005 Nov 1;192(9):1658-65
16206083
Protein Sci. 2000 Apr;9(4):704-12
10794412